Sign up to our newsletter

NGAL (neutrophil gelatinase-associated lipocalin) is a small glycoprotein found in blood and urine. It is expressed by kidney tubular cells after kidney injury and it has been indicated as a promising biomarker of acute kidney injury. In addition, NGAL concentration is known to increase in severe infections.

We provide several mouse and rabbit derived monoclonal antibodies specific to human NGAL. In addition, we have developed a recombinant NGAL protein that can be used as a calibrator or standard in NGAL immunoassays.

Traumatic brain injuries (TBIs), including concussions, are one of the main public health concerns globally. TBI diagnosis is currently based on clinical assessment using scores such as Glasgow coma scale and computer tomography. However, scores can be compromised for various reasons and the computer tomography is less than perfect too as even in severe cases the findings can be normal.

With effect from October 2019, Karen has been the North America Sales Manager of HyTest.

Our researchers wrote an editorial for a Clinical Chemistry article addressing an important but poorly studied interrelationship between obesity and natriuretic peptide measurements.

We will be attending Medica 2019 in November.

We are delighted to introduce our latest team member, CCO Juhana Rauramo.

Using several immunodiagnostic techniques, our researchers investigated in what forms cTnI and cTnT (as components of the troponin complexes) are present in the blood of patients with acute myocardial infarction.

The article describes the development of a novel immunoassay for the quantification of BNP fragments cleaved by neprilysin.

Alzheimer’s disease is a progressive neurodegenerative disease and the most common cause of dementia. We provide three in vitro produced monoclonal antibodies that are specific to human beta-amyloid 1-42.

23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine - EuroMedLab 2019 was held in Barcelona, May 2019.

During our 25th anniversary year in collaboration with EFLM through the sponsorship of their award, we have had an excellent opportunity to show our appreciation towards scientific work in the field of cardiovascular diseases. Read more about our anniversary year campaign Challenge25 here.

Anti-Müllerian hormone (AMH) is a dimeric glycoprotein that is produced by granulosa cells in females and it is currently considered to be the most reliable biomarker for the assessment of ovarian reserve in women.